Tag 'Signal Management'

Introduction  Expanding a pharmaceutical product into a new country can open significant opportunities for growth, but market entry is not simply a regulatory submission or…

Introduction  Brazil has established a comprehensive pharmacovigilance framework designed to ensure the continuous monitoring of the safety and benefit–risk profile of medicinal products throughout their…

Introduction  In today’s global pharmaceutical environment, medicinal products are often developed, manufactured, marketed, and distributed across multiple countries and by several organizations. As a result,…

Introduction  In pharmacovigilance, the identification of a potential safety signal is the beginning of a structured scientific and regulatory process—not the conclusion. A safety signal…

Pharmacovigilance (PV) inspections are no longer viewed as isolated regulatory events—they are an essential mechanism for ensuring that Marketing Authorization Holders (MAHs) maintain effective pharmacovigilance systems that…

In the evolving landscape of pharmacovigilance, signal management has become a central pillar in ensuring drug safety and maintaining compliance with global regulatory affairs…

The FDA maintains a rigorous post-market surveillance system to protect public health through advanced Pharmacovigilance. Central to this is the FAERS (FDA Adverse Event Reporting…

In the current pediatric healthcare landscape, ensuring medication safety for children remains a critical challenge for global medical science. While adverse drug reactions (ADRs) are…